• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports Fourth Quarter and Full Year 2024 Financial Results

    3/11/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Achieved Annual Net Sales of $568 Million, Gross Margin of 41.1% and Net Income of $36 Million

    Generated Record Annual Adjusted EBITDA and Adjusted EBITDA Margin for Second Consecutive Year

    Expects Full Year 2025 Net Sales of $572 to $601 Million and Adjusted EBITDA of $105 to $115 Million

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the quarter and year ended December 31, 2024.

    • Net sales of $176.0 million for the fourth quarter; net sales of $567.6 million for the year ended December 31, 2024.
    • Gross profit margin of 43.9% for the fourth quarter; gross profit margin of 41.1% for the year ended December 31, 2024.
    • Net income of $13.0 million, or $0.32 per diluted share, for the fourth quarter; net income of $36.1 million, or $0.90 per diluted share, for the year ended December 31, 2024.
    • Adjusted EBITDA of $38.5 million for the fourth quarter; Adjusted EBITDA of $104.8 million for the year ended December 31, 2024.
    • Adjusted EBITDA margin of 21.9% for the fourth quarter; Adjusted EBITDA margin of 18.5% for the year ended December 31, 2024.
    • Declared quarterly cash dividend of $0.095 per share in January 2025. On an annualized basis, this dividend represents an increase of $0.03 per share, or 8.6% per share, over the previous annualized dividend of $0.35 per share.

    "2024 was another record year, as our teams continued to leverage the Cadre operating model and capitalize on positive demand trends for our best-in-class, mission-critical safety equipment," said Warren Kanders, CEO and Chairman. "We delivered our full-year guidance of double-digit revenue and adjusted EBITDA growth, driven by high-level execution in Q4, which represented Cadre's best quarter of financial results as a public company. We achieved significantly higher net sales and adjusted EBITDA, while expanding full year adjusted EBITDA margins 70 basis points year-over-year."

    Mr. Kanders added, "We've carried this momentum forward into 2025 and are pleased to have agreed to acquire multiple leading nuclear safety brands, as announced in January. The acquisition of the Engineering Division from Carr's Group accomplishes multiple key objectives for Cadre, which includes adding scale to our nuclear vertical, growing our international footprint and expanding our nuclear TAM with entry into automation, robotics and nuclear medicine. We continue to evaluate a robust pipeline of additional M&A opportunities consistent with our highly selective key criteria focused on companies with strong margins, leading and defensible market positions, as well as recurring revenues and cash flows."

    Mr. Kanders concluded, "Cadre has established a track record of consistent and stable growth through cycles, and we continue to see a commitment globally to prioritizing public safety and ensuring those who protect and serve us are equipped with the most secure and reliable products. Moving forward, we believe Cadre is ideally positioned to further expand our leadership positions in safety markets, including the nuclear market, and build value for customers and shareholders. While there are a number of uncertainties in the current operating environment, we are confident in Cadre's long-term outlook and remain focused on taking advantage of both organic and inorganic opportunities ahead."

    Fourth Quarter and Year-End 2024 Operating Results

    For the quarter ended December 31, 2024, Cadre generated net sales of $176.0 million, as compared to $124.6 million for the quarter ended December 31, 2023, primarily as a result of recent acquisitions and strong shipments for Armor and Duty Gear.

    For the year ended December 31, 2024, Cadre generated net sales of $567.6 million, as compared to $482.5 million for the year ended December 31, 2023, primarily as a result of recent acquisitions and higher demand for armor, duty gear products, and hard goods.

    For the quarter ended December 31, 2024, Cadre generated gross profit of $77.2 million, as compared to $49.8 million for the quarter ended December 31, 2023. For the year ended December 31, 2024, Cadre generated gross profit of $233.5 million, as compared to $200.7 million for the prior year period.

    Gross profit margin was 43.9% for the quarter ended December 31, 2024, as compared to 39.9% for the quarter ended December 31, 2023, mainly driven by volume leverage on higher shipments. Gross profit margin was 41.1% for the year ended December 31, 2024, as compared to 41.6% for the prior year period.

    Net income was $13.0 million for the quarter ended December 31, 2024, as compared to net income of $9.6 million for the quarter ended December 31, 2023, primarily as a result of increased gross profit year over year.

    Net income was $36.1 million for the year ended December 31, 2024, as compared to net income of $38.6 million for the prior year period, primarily as a result of an increase in selling, general and administrative expenses from acquisitions, acquisition related costs, higher interest expense and lower productivity, partially offset by favorable pricing and increased volume.

    Cadre generated $38.5 million of Adjusted EBITDA for the quarter ended December 31, 2024, as compared to $20.7 million for the quarter ended December 31, 2023. Adjusted EBITDA margin was 21.9% for the quarter ended December 31, 2024, as compared to 16.6% for the prior year period.

    Cadre generated $104.8 million of Adjusted EBITDA for the year ended December 31, 2024, as compared to $85.8 million for the prior period. Adjusted EBITDA margin was 18.5% for the year ended December 31, 2023, as compared to 17.8% for the prior year period.

    Product segment gross margin was 45.4% and 42.2% for the fourth quarter and full year 2024, respectively, compared to 40.7% and 43.1% for the prior year periods.

    Distribution segment gross margin was 21.8% and 22.5% for the fourth quarter and full year 2024, respectively, compared to 23.9% and 23.5% for the prior year periods.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents increased by $37.2 million from $87.7 million as of December 31, 2023 to $124.9 million as of December 31, 2024.
    • Total debt increased by $83.1 million from $140.1 million as of December 31, 2023 to $223.2 million as of December 31, 2024.
    • Net debt (total debt net of cash and cash equivalents) increased by $45.8 million from $52.4 million as of December 31, 2023 to $98.3 million as of December 31, 2024.
    • Capital expenditures totaled $1.4 million for the fourth quarter and $5.8 million for the year ended December 31, 2024, compared with $2.7 million for the fourth quarter and $7.0 million for the year ended December 31, 2023.

    Expansion of Credit Facilities

    On December 23, 2024 Cadre announced the closing of a new credit agreement that provides senior secured credit facilities of up to $590 million and matures in five years. The financing consists of a five-year undrawn revolving credit facility of $175 million, a five-year term loan facility of $225 million, as well as two delayed draw term loans of up to $115 million and $75 million, respectively (collectively, the "Credit Facilities"). The revolving credit facility and $225 million term loan are expected to be used for working capital and general corporate purposes, as well as to refinance existing outstanding debt. Subject to the conditions contained in the Credit Facilities, the $115 million delayed draw term loan is available to the Company for six months from the closing of the facilities to support current acquisition activity, while the $75 million delayed draw term facility is available to the Company for eighteen months from the closing to support future opportunities. The $75 million delayed draw term facility is also available for general corporate purposes. Combined with $124.9 million of cash and cash equivalents as of December 31, 2024, this provides Cadre with $489.9 million of capital to pursue its growth objectives.

    Acquisition of Carr's Engineering Division

    On January 15, 2025, Cadre announced it has entered into a definitive agreement to acquire Carr's Engineering Limited (excluding Chirton Engineering) and Carr's Engineering (US), Inc. (together the "Engineering Division"), each a subsidiary of Carr's Group plc ("Carr's Group"), for an enterprise value of £75 million payable in cash at completion. The Engineering Division is comprised of industry-leading brands including Wälischmiller GmbH, CarrsMSM, Bendalls Engineering, NW Total Engineered Solutions, and NuVision Engineering, Inc. With sites in the United Kingdom, Germany and the United States, the Engineering Division designs, manufactures and services equipment, vessels, precision components and remote handling systems for nuclear end-markets. The brands within the Engineering Division are highly complementary to Cadre's nuclear safety business and, upon closing, will both expand the Company's presence in international markets and provide entry into new product categories within the nuclear market segment.

    Increased Dividend

    On January 21, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis, which represents an increase of $0.03 per share, or 8.6% per share, over the previous annualized dividend of $0.35 per share. Cadre's dividend payment was made on February 14, 2025 to shareholders of record as of the close of business on the record date of January 31, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2025 Outlook

    For the full year 2025, Cadre expects to generate net sales in the range of $572 million to $601 million and Adjusted EBITDA in the range of $105 million and $115 million. We expect capital expenditures to be in the range of $7 million to $9 million. This guidance does not include any impact from the recently announced or implemented U.S. tariffs. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA. Therefore, we do not provide a reconciliation of Adjusted EBITDA guidance to net income guidance.

    Conference Call

    Management will host a conference call on Wednesday, March 12, 2025, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 3272793. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through March 26, 2025. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 3272793.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA and (iii) adjusted EBITDA margin. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    December 31,

     

     

    2024

     

     

    2023

     

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    124,933

     

     

    $

    87,691

     

    Accounts receivable, net

     

     

    93,523

     

     

     

    58,360

     

    Inventories

     

     

    82,351

     

     

     

    80,976

     

    Prepaid expenses

     

     

    19,027

     

     

     

    11,930

     

    Other current assets

     

     

    7,737

     

     

     

    6,886

     

    Total current assets

     

     

    327,571

     

     

     

    245,843

     

    Property and equipment, net

     

     

    45,243

     

     

     

    44,647

     

    Operating lease assets

     

     

    15,454

     

     

     

    6,554

     

    Deferred tax assets, net

     

     

    4,552

     

     

     

    4,004

     

    Intangible assets, net

     

     

    107,544

     

     

     

    43,472

     

    Goodwill

     

     

    148,157

     

     

     

    81,667

     

    Other assets

     

     

    4,192

     

     

     

    4,992

     

    Total assets

     

    $

    652,713

     

     

    $

    431,179

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    29,644

     

     

    $

    28,418

     

    Accrued liabilities

     

     

    46,413

     

     

     

    44,524

     

    Income tax payable

     

     

    6,693

     

     

     

    9,944

     

    Current portion of long-term debt

     

     

    11,375

     

     

     

    12,320

     

    Total current liabilities

     

     

    94,125

     

     

     

    95,206

     

    Long-term debt

     

     

    211,830

     

     

     

    127,812

     

    Long-term operating lease liabilities

     

     

    10,733

     

     

     

    3,186

     

    Deferred tax liabilities

     

     

    18,758

     

     

     

    4,843

     

    Other liabilities

     

     

    5,752

     

     

     

    2,970

     

    Total liabilities

     

     

    341,198

     

     

     

    234,017

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and December 31, 2023)

     

     

    —

     

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,607,988 and 37,587,436 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively)

     

     

    4

     

     

     

    4

     

    Additional paid-in capital

     

     

    306,821

     

     

     

    212,630

     

    Accumulated other comprehensive (loss) income

     

     

    (1,389

    )

     

     

    634

     

    Accumulated earnings (deficit)

     

     

    6,079

     

     

     

    (16,106

    )

    Total shareholders' equity

     

     

    311,515

     

     

     

    197,162

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    652,713

     

     

    $

    431,179

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

    Net sales

     

    $

    175,984

     

     

    $

    124,583

     

     

    $

    567,561

     

     

    $

    482,532

     

    Cost of goods sold

     

     

    98,797

     

     

     

    74,825

     

     

     

    334,080

     

     

     

    281,806

     

    Gross profit

     

     

    77,187

     

     

     

    49,758

     

     

     

    233,481

     

     

     

    200,726

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

     

    45,046

     

     

     

    34,904

     

     

     

    158,323

     

     

     

    140,519

     

    Restructuring and transaction costs

     

     

    2,386

     

     

     

    1,060

     

     

     

    6,007

     

     

     

    2,192

     

    Related party expense

     

     

    352

     

     

     

    1,117

     

     

     

    2,390

     

     

     

    1,496

     

    Total operating expenses

     

     

    47,784

     

     

     

    37,081

     

     

     

    166,720

     

     

     

    144,207

     

    Operating income

     

     

    29,403

     

     

     

    12,677

     

     

     

    66,761

     

     

     

    56,519

     

    Other expense

     

     

     

     

     

     

     

     

     

     

     

     

    Interest expense

     

     

    (2,191

    )

     

     

    (804

    )

     

     

    (7,822

    )

     

     

    (4,531

    )

    Other (expense) income, net

     

     

    (4,496

    )

     

     

    541

     

     

     

    (4,721

    )

     

     

    936

     

    Total other expense, net

     

     

    (6,687

    )

     

     

    (263

    )

     

     

    (12,543

    )

     

     

    (3,595

    )

    Income before provision for income taxes

     

     

    22,716

     

     

     

    12,414

     

     

     

    54,218

     

     

     

    52,924

     

    Provision for income taxes

     

     

    (9,733

    )

     

     

    (2,820

    )

     

     

    (18,085

    )

     

     

    (14,283

    )

    Net income

     

    $

    12,983

     

     

    $

    9,594

     

     

    $

    36,133

     

     

    $

    38,641

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.32

     

     

    $

    0.26

     

     

    $

    0.90

     

     

    $

    1.03

     

    Diluted

     

    $

    0.32

     

     

    $

    0.25

     

     

    $

    0.90

     

     

    $

    1.02

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    40,607,988

     

     

     

    37,586,756

     

     

     

    39,945,982

     

     

     

    37,533,818

     

    Diluted

     

     

    40,977,622

     

     

     

    38,125,787

     

     

     

    40,332,042

     

     

     

    37,920,488

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31,

     

     

    2024

     

     

    2023

     

     

    2022

     

    Cash Flows From Operating Activities:

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    36,133

     

     

    $

    38,641

     

     

    $

    5,820

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    16,420

     

     

     

    15,737

     

     

     

    15,651

     

    Amortization of original issue discount and debt issue costs

     

     

    1,109

     

     

     

    479

     

     

     

    740

     

    Amortization of inventory step-up

     

     

    3,858

     

     

     

    —

     

     

     

    4,255

     

    Deferred income taxes

     

     

    (2,064

    )

     

     

    (210

    )

     

     

    (1,087

    )

    Stock-based compensation

     

     

    8,369

     

     

     

    9,368

     

     

     

    31,858

     

    Remeasurement of contingent consideration

     

     

    1,185

     

     

     

    —

     

     

     

    —

     

    Provision for losses on accounts receivable

     

     

    764

     

     

     

    66

     

     

     

    417

     

    Unrealized foreign exchange transaction loss (gain)

     

     

    1,880

     

     

     

    (602

    )

     

     

    1,517

     

    Other loss (gain)

     

     

    496

     

     

     

    (381

    )

     

     

    (170

    )

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

     

     

     

    Accounts receivable

     

     

    (24,902

    )

     

     

    6,602

     

     

     

    (11,536

    )

    Inventories

     

     

    10,019

     

     

     

    (10,223

    )

     

     

    1,162

     

    Prepaid expenses and other assets

     

     

    (5,866

    )

     

     

    (302

    )

     

     

    (7,711

    )

    Accounts payable and other liabilities

     

     

    (15,624

    )

     

     

    14,034

     

     

     

    5,493

     

    Net cash provided by operating activities

     

     

    31,777

     

     

     

    73,209

     

     

     

    46,409

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (5,668

    )

     

     

    (6,727

    )

     

     

    (4,494

    )

    Proceeds from disposition of property and equipment

     

     

    55

     

     

     

    207

     

     

     

    411

     

    Business acquisitions, net of cash acquired

     

     

    (141,813

    )

     

     

    —

     

     

     

    (55,543

    )

    Net cash used in investing activities

     

     

    (147,426

    )

     

     

    (6,520

    )

     

     

    (59,626

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    5,500

     

     

     

    —

     

     

     

    43,000

     

    Principal payments on revolving credit facilities

     

     

    (5,500

    )

     

     

    —

     

     

     

    (43,000

    )

    Proceeds from term loans

     

     

    129,422

     

     

     

    —

     

     

     

    —

     

    Principal payments on term loans

     

     

    (43,334

    )

     

     

    (10,000

    )

     

     

    (10,116

    )

    Proceeds from insurance premium financing

     

     

    —

     

     

     

    3,949

     

     

     

    3,989

     

    Principal payments on insurance premium financing

     

     

    (2,187

    )

     

     

    (3,973

    )

     

     

    (4,952

    )

    Payments for debt issuance costs

     

     

    (3,105

    )

     

     

    —

     

     

     

    —

     

    Taxes paid in connection with employee stock transactions

     

     

    (5,311

    )

     

     

    (2,725

    )

     

     

    (6,300

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    91,776

     

     

     

    —

     

     

     

    56,329

     

    Deferred offering costs

     

     

    (683

    )

     

     

    —

     

     

     

    (2,953

    )

    Dividends distributed

     

     

    (13,948

    )

     

     

    (12,006

    )

     

     

    (11,509

    )

    Other

     

     

    37

     

     

     

    33

     

     

     

    (25

    )

    Net cash provided by (used in) financing activities

     

     

    152,667

     

     

     

    (24,722

    )

     

     

    24,463

     

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    224

     

     

     

    438

     

     

     

    183

     

    Change in cash and cash equivalents

     

     

    37,242

     

     

     

    42,405

     

     

     

    11,429

     

    Cash and cash equivalents, beginning of period

     

     

    87,691

     

     

     

    45,286

     

     

     

    33,857

     

    Cash and cash equivalents, end of period

     

    $

    124,933

     

     

    $

    87,691

     

     

    $

    45,286

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    24,207

     

     

    $

    8,729

     

     

    $

    1,395

     

    Cash paid for interest

     

    $

    14,431

     

     

    $

    10,090

     

     

    $

    6,109

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    176

     

     

    $

    234

     

     

    $

    172

     

    Accruals and accounts payable for debt issuance costs

     

    $

    166

     

     

    $

    —

     

     

    $

    —

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    153,913

     

    $

    33,782

     

    $

    (11,711

    )

     

    $

    175,984

    Cost of goods sold

     

     

    84,093

     

     

    26,415

     

     

    (11,711

    )

     

     

    98,797

    Gross profit

     

    $

    69,820

     

    $

    7,367

     

    $

    —

     

     

    $

    77,187

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31, 2023

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    105,768

     

    $

    27,777

     

    $

    (8,962

    )

     

    $

    124,583

    Cost of goods sold

     

     

    62,733

     

     

    21,135

     

     

    (9,043

    )

     

     

    74,825

    Gross profit

     

    $

    43,035

     

    $

    6,642

     

    $

    81

     

     

    $

    49,758

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    497,624

     

    $

    105,397

     

    $

    (35,460

    )

     

    $

    567,561

    Cost of goods sold

     

     

    287,864

     

     

    81,631

     

     

    (35,415

    )

     

     

    334,080

    Gross profit

     

    $

    209,760

     

    $

    23,766

     

    $

    (45

    )

     

    $

    233,481

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year Ended December 31, 2023

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    410,825

     

    $

    102,371

     

    $

    (30,664

    )

     

    $

    482,532

    Cost of goods sold

     

     

    233,937

     

     

    78,335

     

     

    (30,466

    )

     

     

    281,806

    Gross profit

     

    $

    176,888

     

    $

    24,036

     

    $

    (198

    )

     

    $

    200,726

    _______________________
    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

     

     

    2024

     

    2023

     

     

    2024

     

    2023

     

     

    Net income

     

    $

    12,983

     

    $

    9,594

     

     

    $

    36,133

     

    $

    38,641

     

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    4,095

     

     

    3,352

     

     

     

    16,420

     

     

    15,737

     

     

    Interest expense

     

     

    2,191

     

     

    804

     

     

     

    7,822

     

     

    4,531

     

     

    Provision for income taxes

     

     

    9,733

     

     

    2,820

     

     

     

    18,085

     

     

    14,283

     

     

    EBITDA

     

    $

    29,002

     

    $

    16,570

     

     

    $

    78,460

     

    $

    73,192

     

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    2,386

     

     

    2,060

     

     

     

    7,757

     

     

    3,192

     

     

    Other general income(2)

     

     

    —

     

     

    (92

    )

     

     

    —

     

     

    (92

    )

     

    Other expense (income), net(3)

     

     

    4,496

     

     

    (541

    )

     

     

    4,721

     

     

    (936

    )

     

    Stock-based compensation expense(4)

     

     

    2,114

     

     

    2,308

     

     

     

    8,369

     

     

    9,368

     

     

    Stock-based compensation payroll tax expense(5)

     

     

    —

     

     

    14

     

     

     

    441

     

     

    234

     

     

    LTIP bonus(6)

     

     

    —

     

     

    371

     

     

     

    49

     

     

    860

     

     

    Amortization of inventory step-up(7)

     

     

    7

     

     

    —

     

     

     

    3,858

     

     

    —

     

     

    Contingent consideration expense(8)

     

     

    500

     

     

    —

     

     

     

    1,185

     

     

    —

     

     

    Adjusted EBITDA

     

    $

    38,505

     

    $

    20,690

     

     

    $

    104,840

     

    $

    85,818

     

     

    Adjusted EBITDA margin(9)

     

     

    21.9

    %

     

    16.6

    %

     

    18.5

    %

     

    17.8

    %

    _________________________

    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statements of operations, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.8 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the year ended December 31, 2024 and a $1.0 million fee paid to Kanders & Company, Inc. for services related to the acquisition of ICOR for the year ended December 31, 2023, which are included in related party expense in the Company's consolidated statements of operations.

    (2)

    Reflects gains from long-lived asset sales.

    (3)

    Reflects the "Other (expense) income, net" line item on our consolidated statements of operations and comprehensive income and primarily includes transaction gains and losses due to fluctuations in foreign currency exchange rates.

    (4)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

    (5)

    Reflects payroll taxes associated with vested stock-based compensation awards.

    (6)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    (7)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

    (8)

    Reflects contingent consideration expense related to the acquisition of ICOR.

    (9)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250311633138/en/

    Gray Hudkins

    Cadre Holdings, Inc.

    203-550-7148

    [email protected]

    Investor Relations:

    The IGB Group

    Leon Berman / Matt Berkowitz

    212-477-8438 / 212-227-7098

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Financials

    Live finance-specific insights

    See more

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care